Day: October 4, 2022

Riot Produces 355 Bitcoin in September 2022 and Significantly Expands Hash Rate Capacity to All-Time RecordRiot’s Rockdale Facility For the month of September, Riot engineering and construction teams made significant progress on the Company’s 400 megawatt (“MW”) digital infrastructure expansion project. In Building D, miner deployments have begun, and engineers are 90% complete with installing Riot’s proprietary air-cooling rack system. Installation and testing of low voltage cables have also been completed. In Riot’s second immersion-cooled building, Building G, over half of total miner capacity has been deployed.Riot Blockchain Hash Rate Capacity Growth Updated September 2022 During Q1 2023, Riot anticipates a total self-mining hash rate capacity of 12.5 EH/s, assuming full deployment of approximately...

Company to empower government and commercial attendees to protect their assets and workforces from fraud with unmatched biometric authentication expertise BURLINGTON, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a leading authentication company applying proven and trusted adaptive authentication to solve everyday business challenges with biometrics, is bringing its full portfolio of world-class authentication solutions to this year’s Identity Week America conference. This leading industry event will take place from October 4-5 in Washington D.C. Government and commercial institutions are experiencing an evolution of digital identity and access management solutions. With data breaches and identity theft on the rise and increasingly mobile workforces, providers need fool-proof, reliable identification and authentication...

SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Astra Energy Inc. (OTC: ASRE) (“Astra” or the “Company”), a global integrated energy solutions provider specializing in clean and renewable energy and technology, announces that its public market listing has been successfully upgraded from the OTC Pink Sheet Open Market to the OTCQB® Venture Market (“OTCQB”) by the OTC Markets Group Inc. (“OTC Markets”). “This market listing upgrade serves as an important milestone toward further expansion of our market presence in North America and internationally, providing a broader opportunity to attract a larger shareholder audience,” stated Kermit Harris, president and director of Astra Energy Inc. The Company’s listing of its common shares was upgraded on Friday, Sept. 30, 2022, and will continue to trade under the symbol...

Southfield, MI, Oct. 04, 2022 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company” and “Sun”), a real estate investment trust (“REIT”) that owns and operates, or has an interest in, manufactured housing (“MH”) communities, recreational vehicle (“RV”) resorts and marinas, is providing a preliminary assessment of the impact of Hurricane Ian on the Company’s properties in Florida. The Company has access to all its properties and assessments are in the early stages. Restoration and cleanup activities have begun at all affected properties. Convoys of supplies, food, travel trailers, and trucks, all assembled and organized by Sun team members, have been delivered to Sun’s Florida properties. The Company continues to evaluate the impact of the storm. Three RV properties in the Fort Myers...

SAN DIEGO and TAICANG, China, Oct. 04, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Connect Biopharma Holdings Limited (Nasdaq: CNTB), please note that in the “About the Trial” section, the fourth sentence should read “Stage 2 36-week maintenance period”, not “Stage 2 16-week maintenance period” as previously stated. The corrected release follows:All primary and key secondary endpoints were met and highly significant at Week 16 in 255 adult patients with moderate-to-severe AD Safety and tolerability results for CBP-201 consistent with targeting the IL-4Rα pathway Data support advancing the regulatory discussions with the CDE for submitting an NDA in China Conference call to discuss these data will be held today at 5:30am PDT/8:30am EDTConnect Biopharma...

TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX:YRI; NYSE:AUY; LSE:AUY) (“Yamana” or “the Company”) announces that it will release its operational and financial results for the third quarter of this year after the market closes on Thursday, October 27, 2022. The Company will host a conference call and webcast to review the results on Friday, October 28, 2022 at 9:00 a.m. Eastern Daylight Time. Yamana further announces that it has filed the required notice setting a record and meeting dates in respect of the special meeting of shareholders to consider the previously announced proposed transaction with Gold Fields Limited (“Gold Fields”). The record date, which is the date of record for determination of shareholders entitled to receive notice of and vote at the special meeting of shareholders, is set as October 18,...

JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein production and unmet clinical needs for effective and affordable biopharmaceutical products for human and animal health, today announced that its Chief Executive Officer, Mark Emalfarb will be presenting at the upcoming World Vaccine Congress in Barcelona, Spain. The presentation will highlight significant achievements, including:Successful expression of Omicron BA.5 RBD and gRBD ferritin nano particle antigens including Wuhan and Omicron BA.2 from C1 cells. Nanoparticle antigens have demonstrated the potential to lead to broader and longer lasting protection against a number of...

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today announced the pricing of an underwritten offering of 12,500,000 shares of its common stock at an offering price of $6.00 per share. Investors who have agreed to purchase shares in the offering include Logos Capital, Deep Track Capital, Frazier Life Sciences, TCGX, BVF Partners L.P., Commodore Capital, and an undisclosed healthcare specialist fund. Before deducting the underwriting discounts and commissions and offering expenses, the company expects to receive total gross proceeds of $75.0 million. The company intends to use the net proceeds from this offering, together with its existing cash, to accelerate the development of IMVT-1402,...